Latest News about SNY
Recent news which mentions SNY
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
From Benzinga
Earnings Scheduled For July 28, 2022
July 28, 2022
From Benzinga
From Benzinga
From Benzinga
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace
July 24, 2022
From Benzinga
3 High-Margin Businesses That Can Absorb Inflation
July 20, 2022
From Motley Fool
Pasithea's Latest Drug Candidate Could Bring New Hope To ALS Patients Without Effective Treatment Options
July 20, 2022
From Benzinga
Clovis Oncology (CLVS) Stock Pops 7% on Supply Agreement
July 19, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From Benzinga
SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis
July 11, 2022
From Benzinga
Stock Split Watch: Could Regeneron Be Next?
July 11, 2022
From Motley Fool
Is Sanofi on the Verge of Another Blockbuster?
July 09, 2022
From Motley Fool
3 No-Brainer Stocks to Buy in July
July 09, 2022
From Motley Fool
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market
July 07, 2022
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.